Nurix Therapeutics Inc (NRIX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,388,016,000
EV to revenue ratio (TTM)
56.9
EV to ebitda
-3.345
Financial Performance
Revenue (TTM)
36,766,000
Gross profit (TTM)
-304,167,008
EBITDA
-353,180,000
Profitability
Operating margin (TTM)
-1,042.00%
Profit margin
0.00%
Return on assets (TTM)
-40.10%
Return on equity (TTM)
-80.30%
Per Share Metrics
Revenue per share (TTM)
0.37
EPS
-3.46
Diluted EPS (TTM)
-3.46
Book value
3.88
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
64.95
Price to book ratio (TTM)
6.15
Growth
Quarterly earnings growth (YoY)
-79.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
5
Buy
9
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.802